Neurotransmitters play an important role in transmitting information between neurons across the synaptic cleft. Various regions and pathways in the brain use different patterns of neurotransmitters and different receptor subclasses, which helps to identify the role specific neurotransmitters play in various psychiatric conditions in neuroimaging studies and can also make medication more specific. Neurotransmitters are […]

Neurotransmitters Read More »

Serotonin, Norepinephrine, Dopamine – Combining Medication against Depression

Serotonin, Norepinephrin, Dopamine – Combining Medication against Depression Christian Jonathan Haverkampf, M.D. A monotherapy or a combination of antidepressants that affect all three monoamines serotonin, dopamine and norepinephrine together have led to some positive results in cases of treatment-resistant depression, while some promising substances that could be used as monotherapy are still in the early

Serotonin, Norepinephrine, Dopamine – Combining Medication against Depression Read More »

Psychopharmacological Frontiers (1)

Psychopharmacological Frontiers Christian Jonathan Haverkampf, M.D. New developments in psychopharmacology have driven much of the progress over the last decades. This article discusses new developments in the area of antidepressants and antipsychotics. Keywords: depression, SSRI, SNRI, ketamine, glutamate antagonist, NMDA, scopolamine, magnesium, glutamine, CP-AMPA, serotonin, norepinephrine, dopamine, antidepressants, major depressive disorder, medication, treatment psychiatry Table

Psychopharmacological Frontiers (1) Read More »